← Browse by Condition
Medical Condition
advanced renal cell carcinoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 1
NCT07227415 Phase 1, Phase 2
Recruiting
A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Enrollment
224 pts
Location
United States, Austr...
Sponsor
Pfizer
NCT06265285 Phase 2
Recruiting
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Enrollment
50 pts
Location
United States
Sponsor
Mayo Clinic
NCT05868174 Phase 1
Recruiting
Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
Enrollment
36 pts
Location
Australia
Sponsor
Telix Pharmaceuticals (Innovat...